The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

At 3 years, Agent still outshined uncoated balloons. Registry data show rapid uptake of the DCB in the year after its FDA approval.

Immediate revascularization of nonculprit lesions in patients with STEMI was not superior compared with deferred percutaneous coronary intervention of nonculprit lesions out to 3 years, researchers ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) previously reported that the da Vinci 5 system was cleared by the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac ...

For the 11 million Americans living with angina, chronic chest pain caused by a lack of blood flow to the heart muscle can touch every aspect of daily ...

It is important for researchers to develop and implement methods to improve representation of participants from diverse backgrounds and to improve the accuracy of reporting study subject demographics.

And check out 314 Pi Day by Uhuru Pies on the St. Louis Patch calendar ...

Today at the Cardiovascular Research Technologies (CRT) annual conference taking place in Washington, DC, Dr. Christopher ...

2026年3月6日，美国神经外科医师协会（AANS）主办的国际知名神经外科专业期刊Journal of Neurosurgery杂志（中科院2区Top/Q1/3.6）在线发表了美国Cedars-Sinai Medical ...

Mercy Hospital St. Louis has become the first and only hospital in Missouri to offer an innovative, less invasive alternative to open-heart coronary artery bypass surgery. Called hybrid coronary ...

The HighLife Transcatheter Mitral Valve Replacement (TMVR) system achieves a 90% technical success rate and effectively eliminates leakage in 88% of high-risk patients, as a recent study has shown.